AI Spotlight on NOVT
Company Description
Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide.The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions.
In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles.The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands.The company was formerly known as GSI Group, Inc.
and changed its name to Novanta Inc.in May 2016.Novanta Inc.
was founded in 1968 and is headquartered in Bedford, Massachusetts.
Market Data
Last Price | 149.66 |
Change Percentage | 0.40% |
Open | 149.47 |
Previous Close | 149.07 |
Market Cap ( Millions) | 5376 |
Volume | 203379 |
Year High | 187.12 |
Year Low | 143.18 |
M A 50 | 158.49 |
M A 200 | 166.77 |
Financial Ratios
FCF Yield | 1.94% |
Dividend Yield | 0.00% |
ROE | 8.59% |
Debt / Equity | 69.29% |
Net Debt / EBIDTA | 260.67% |
Price To Book | 7.25 |
Price Earnings Ratio | 89.49 |
Price To FCF | 51.63 |
Price To sales | 5.83 |
EV / EBITDA | 35.85 |
News
- Dec -19 - Novanta to Present at the CJS Securities 25th Annual New Ideas for the New Year Investor Conference on Tuesday, January 14, 2025
- Nov -05 - Novanta Inc. (NOVT) Q3 2024 Earnings Call Transcript
- Nov -05 - Novanta (NOVT) Q3 Earnings Miss Estimates
- Sep -17 - 4 Top Electronics Stocks With Bright Industry Prospects to Buy
- Aug -12 - 3 Robotics Stocks to Buy and Hold for the Potential of Huge Returns
- Aug -06 - Novanta Inc. (NOVT) Q2 2024 Earnings Call Transcript
- Aug -06 - Novanta (NOVT) Tops Q2 Earnings and Revenue Estimates
- Jul -15 - Novanta (NOVT) Soars 3.8%: Is Further Upside Left in the Stock?
- Jun -19 - 4 Top Electronics Stocks to Beat Macroeconomic Headwinds
- May -09 - What Makes Novanta (NOVT) a New Buy Stock
- May -07 - Novanta (NOVT) Tops Q1 Earnings and Revenue Estimates
- May -07 - Novanta Announces Financial Results for the First Quarter 2024
- May -01 - Novanta to Present at Baird's 2024 Global Consumer, Technology & Services Conference on Wednesday, June 5, 2024
- Apr -09 - Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 7, 2024
- Apr -01 - 3 Top Electronics Stocks to Overcome Industry Headwinds
- Feb -28 - Novanta (NOVT) Meets Q4 Earnings Estimates
- Jan -29 - Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, February 28, 2024
- Jan -02 - Novanta completes acquisition of Motion Solutions
- Dec -11 - Novanta to Present at the J.P. Morgan 42nd Annual Healthcare Conference on Wednesday, January 10, 2024
- Nov -16 - 10 βbetter values' in the stock market, selected for the next two years
Business Breakdown
Expected Mid-Term Growth
Segment nΒ°1 -> Medical Solutions
Expected Growth : 9 %
What the company do ?
Medical Solutions from Novanta Inc. provides innovative medical technologies and equipment for surgical and diagnostic applications, enhancing patient care and outcomes.
Why we expect these perspectives ?
Novanta's Medical Solutions segment growth is driven by increasing demand for minimally invasive surgical procedures, advancements in robotics and digitalization, and a growing need for precision medical components. Additionally, the segment benefits from strategic acquisitions, expanding into new markets, and a strong reputation for quality and innovation.
Segment nΒ°2 -> Precision Medicine and Manufacturing
Expected Growth : 11 %
What the company do ?
Novanta's Precision Medicine and Manufacturing segment provides advanced technologies and components for medical device manufacturing, enabling precise and innovative medical treatments.
Why we expect these perspectives ?
Novanta's Precision Medicine and Manufacturing segment growth is driven by increasing demand for personalized medicine, advancements in gene editing and gene therapy, and adoption of robotics and automation in manufacturing. Additionally, the segment benefits from growing investments in research and development, and strategic acquisitions that expand its product portfolio and geographic reach.
Segment nΒ°3 -> Robotics and Automation
Expected Growth : 8 %
What the company do ?
Novanta's Robotics and Automation segment provides precision motion and vision technologies for industrial, medical, and pharmaceutical applications.
Why we expect these perspectives ?
Novanta's Robotics and Automation segment growth is driven by increasing demand for precision motion and vision technologies in industries such as medical, industrial, and semiconductor manufacturing. The trend towards Industry 4.0 and smart factories also fuels growth, as companies invest in automation and robotics to improve efficiency and productivity.
Novanta Inc. Products
Product Range | What is it ? |
---|---|
Laser Systems | Novanta's laser systems provide high-precision laser processing solutions for various industries, including semiconductor, microelectronics, and industrial manufacturing. |
Photonics Solutions | Novanta's photonics solutions offer a range of optical components, modules, and subsystems for applications in telecommunications, data centers, and industrial manufacturing. |
Vision Systems | Novanta's vision systems provide machine vision solutions for inspection, measurement, and automation in industries such as semiconductor, electronics, and medical devices. |
Precision Motion Systems | Novanta's precision motion systems offer high-precision motion control solutions for industries such as semiconductor, medical devices, and industrial manufacturing. |
Medical Technologies | Novanta's medical technologies provide innovative solutions for medical device manufacturing, including precision motion, vision, and laser systems. |
Novanta Inc.'s Porter Forces
Threat Of Substitutes
Novanta Inc. operates in a niche market with specialized products, reducing the threat of substitutes. However, the company's reliance on a few key customers increases the risk of substitution.
Bargaining Power Of Customers
Novanta Inc.'s customers, including medical device manufacturers and industrial companies, have significant bargaining power due to their large size and negotiating power.
Bargaining Power Of Suppliers
Novanta Inc. has a diversified supplier base, reducing the bargaining power of individual suppliers. The company's strong relationships with suppliers also mitigate the risk of supply chain disruptions.
Threat Of New Entrants
The medical technology and industrial technology markets served by Novanta Inc. have high barriers to entry, including significant capital requirements and regulatory hurdles, reducing the threat of new entrants.
Intensity Of Rivalry
The markets served by Novanta Inc. are moderately competitive, with a few established players competing for market share. However, the company's specialized products and strong customer relationships help to mitigate the intensity of rivalry.
Capital Structure
Value | |
---|---|
Debt Weight | 35.04% |
Debt Cost | 7.33% |
Equity Weight | 64.96% |
Equity Cost | 10.66% |
WACC | 9.49% |
Leverage | 53.94% |
Novanta Inc. : Quality Control
Novanta Inc. passed 3 out of 9 key points:
Historical Valuation
Price/Earnings Ratio
Margin Valuation
Peers Valuation
Competitors
Company | Rational |
---|---|
COHR | Coherent, Inc. provides lasers, laser-based technologies, and laser-based system solutions for a range of commercial, industrial, and scientific research applications. It operates in two segments, Original Equipment Manufacturers (OEM) Laser β¦ |
MKSI | MKS Instruments, Inc. provides instruments, systems, subsystems, and process control solutions that measure, monitor, deliver, analyze, power, and control critical parameters of manufacturing processes worldwide. Its Vacuum & Analysis segment β¦ |
ITRI | Itron, Inc., a technology and service company, provides end-to-end solutions that help manage operations in the energy, water, and smart city space worldwide. The company operates through three segments: Device β¦ |
CGNX | Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the β¦ |
TRMB | Trimble Inc. provides technology solutions that enable professionals and field mobile workers to enhance or transform their work processes worldwide. The company's Buildings and Infrastructure segment offers field and office β¦ |